Job Description

Postdoctoral Associate (f/m/d)

==================================

University Hospital Tübingen, Department of Medicine II, Research Group RNA-Immunotherapies, index number 6932

-------------------------------------------------------------------------------------------------------------------

Full-time

100 %

Limited:

3 years

Start of work:

as soon as possible

Application deadline:

01.01.2026

Tasks

Planning, implementing and performing research experiments Supervision of master students Analysis, interpretation and presentation of research findings Contribution to grant writing, research reports and publications Scientific literature research and development of new ideas

Profile

PhD in biology, biochemistry, life sciences or related discipline Experience with animal work Experience with transcriptomic data analysis prefered Strong interest in RNA-based drugs Excellent English skills (oral and written), German (oral) is encouraged Team-player attitude Creativity and thinking outside the box

Benefits

Work in the diverse environment of a modern university hospital, which focuses not only on patient care but also on medical research and teaching A future-proof job and location, as well as attractive remuneration including a company pension scheme (VBL) and flexible working hours Subsidy for public transport tickets and attractive discounts on our employee offer platforms Structured onboarding phase, hospital-owned academy for developing professional, social and methodological skills Healthcare through a wide range of sports activities

About us

The University Hospital of Tübingen is a leading center of German university medicine. Every year, around 75,000 inpatients and around 380,000 outpatients are treated. With over 11,000 employees, it is the largest employer in the region. The quality of patient care is certified with the KTQ seal of approval.

About the Research Group RNA-Immunotherapies

The research group of Dr.Dr.Haraszti focuses on the preclinical development of RNAi-based drugs to engineer therapeutic immune responses for several hematologic malignancies. We use state-of-the-art RNA technology equivalent to approved RNAi drugs. The overarching goal is transcriptionally repogram immune cells in order to increase efficacy and optimize safety of immunological cell therapies. The specific goal of this postdoctoral position is to develop state-of-the-art tools to deliver advanced RNAi drugs to T cells in vivo, and to define RNAi-responsive, actionable transcriptional programs in T cells in a personalized manner.

Methods:
Animal work – wild type and immunocompromised mice PK / PD of advanced siRNAs CLICK chemistry RNASeq – bulk and single-cell Patient-derived cells Primary Immune Cell Culture Flow cytometry and standard molecular biology BSL2 gene technology work
For more information click here.

Contact for questions

Mrs. Dr.Dr. Reka Haraszti

07071 29-68948

Online Application to

Mrs. Dr.Dr. Reka Haraszti

Index number:

6932

Including CV and cover letter

Application deadline:

01.01.2026

Apply now

Apply via WhatsApp

Back to Jobs

We offer remuneration in accordance with TV-L (collective wage agreement for the Public Service of the German Federal States), severely handicapped persons with equal qualifications are given preferential consideration. Interview expenses are not covered. Please note the applicable vaccination regulations.


#

About the clinic / Department

Learn more
#

We as an employer

Learn more
#

Application FAQ

Learn more